Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PHLDA1 |
| Upstream (Parents) |
|---|
| (<<) ARAF → PHLDA1 |
| (<<) CEBPA → PHLDA1 |
| (<<) DUSP4 → PHLDA1 |
| (<<) IGFBP6 → PHLDA1 |
| (<<) IL23A → PHLDA1 |
| (<<) LTA4H → PHLDA1 |
| (<<) MMP1 → PHLDA1 |
| (<<) MVK → PHLDA1 |
| (<<) PDE2A → PHLDA1 |
| (<<) PKM2 → PHLDA1 |
| (<<) SEPW1 → PHLDA1 |
| (<<) SMTN → PHLDA1 |
| (<<) SOX2 → PHLDA1 |
| (<<) TTC9 → PHLDA1 |
| Downstream (Children) |
|---|
| PHLDA1 → BCAR3 (>>) |
| PHLDA1 → DUSP5 (>>) |
| PHLDA1 → DUSP6 (>>) |
| PHLDA1 → EMILIN2 (>>) |
| PHLDA1 → EPHA4 (>>) |
| PHLDA1 → LDLR (>>) |
| PHLDA1 → PITPNC1 (>>) |
| PHLDA1 → RBL2 (>>) |
| PHLDA1 → TP53 (>>) |
